Along these lines, we might speculate that TLR4 activation, probably due to circulating LPS and/or other PAMPs/DAMPs, plays a pivotal role in Mo pro-inflammatory activity and the related bioenergetic reprogramming observed in patients with MASH. Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.